Homocysteine-lowering interventions in chronic kidney disease

Homocysteine-lowering interventions in chronic kidney disease

The incidence of cardiovascular events and mortality is higher in patients with chronic kidney disease (CKD) compared to the general population. Homocysteine (Hcy) appears to be an independent risk factor for cardiovascular diseases in general populations and patients with CKD. Further, hyperhomocys...

Full description

Bibliographic Details
Main Authors: Shirinsadat Badri, Sahar Vahdat, Shiva Seirafian, Morteza Pourfarzam, Tahereh Gholipur-Shahraki, Sara Ataei
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Journal of Research in Pharmacy Practice
Subjects:
chronic kidney disease
homocysteine
hyperhomocysteinemia
Online Access:http://www.jrpp.net/article.asp?issn=2319-9644;year=2021;volume=10;issue=3;spage=114;epage=124;aulast=Badri

Internet

http://www.jrpp.net/article.asp?issn=2319-9644;year=2021;volume=10;issue=3;spage=114;epage=124;aulast=Badri

Similar Items